EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer

2008145 citationsJournal Article

Authors

Good health and well-being

Published in: International Journal of Radiation Oncology*Biology*Physics

Volume 72, Issue 1, pp. 119-126

Field-Weighted Citation Impact: 4.90